R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Director – Global Medical Information

Biology & BiotechPosted on Nov 12
Full-timeRemote in USA

About the Job

Requirements

  • An advanced degree in a scientific or medical discipline is required; a doctoral degree such as PharmD, MD, or PhD is preferred.
  • At least 10 years of relevant experience is required.
  • Experience in oncology and the ability to critically evaluate clinical trial data and communicate complex scientific information are required.
  • Demonstrated medical information experience in the pharmaceutical or biotechnology industry is required.
  • Experience creating, reviewing, and managing scientific content for diverse audiences is required.
  • Strong organizational, problem-solving, project management, and analytical skills are required, including the ability to monitor and analyze data to inform decisions.
  • Knowledge of regulatory guidelines related to medical information and safety reporting is required.
  • Proficiency in medical information databases, content management systems, and relevant software tools is required.
  • The candidate must be able to negotiate and collaborate effectively with internal stakeholders and external partners.
  • The candidate must be able to prioritize and manage multiple projects in a fast-paced, dynamic environment, make sound decisions, and adapt to changing priorities.
  • Experience managing medical information vendors is required.
  • Willingness to travel approximately 10–20% is required.

Responsibilities

  • Develop and execute medical information strategy and therapeutic-area priorities in alignment with medical strategy leads, regional medical information teams, and other stakeholders.
  • Own the medical information content plan, including the development, review, approval, deployment, and maintenance of standard and custom response letters, FAQs, inquiry response guidance, and special handling instructions.
  • Collaborate with Clinical Operations, Clinical Development, Biology, Medical Strategy, and other stakeholders to interpret emerging evidence, identify information needs, and inform content priorities.
  • Ensure medical information content is evidence-based, consistent, and aligned with current scientific and clinical data.
  • Coordinate with regional leads on localization, regional review, and country implementation of global medical information resources.
  • Support management of unsolicited inquiries from healthcare professionals, patients, and caregivers, ensuring responses are accurate, compliant, and timely.
  • Serve as medical reviewer for therapeutic-area materials through the Medical, Legal and Regulatory process, ensuring evidence-based communication and compliance with company policies, industry standards, and applicable regulations.
  • Partner with the Medical Information Contact Center lead and vendors on agent training, content deployment, response quality, and inquiry escalation; contribute to vendor performance reviews and corrective actions within the therapeutic-area scope.
  • Monitor and analyze inquiry trends to identify operational improvements and inform medical strategy.
  • Monitor scientific publications, clinical trial results, and treatment developments to inform medical information strategy, content updates, and training.
  • Provide medical information support at congresses, including developing resources, staffing booths, and responding to healthcare professional inquiries.
  • Contribute to developing and maintaining internal standard operating procedures and processes to ensure compliance with regulatory requirements and industry standards.
  • Support other Medical Affairs projects as needed.

Desired Qualifications

  • Experience with Veeva PromoMats is advantageous.
  • At least 8 years of experience in Medical Affairs or a related field within the biotechnology or pharmaceutical industry is preferred.
  • Experience in the lung cancer therapeutic area is strongly preferred.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs